Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
deals
3
×
life sciences
national blog main
new york blog main
new york top stories
startups
abbott laboratories
adel malek
aton partners
azacitidine
bayer
beta-thalassemia
carl heilman
cerevasc
chris garabedian
clinical trial
clinical trials
cronos group
dacogen
dan levangie
decitabine
dna
epigenetics
epizyme
farydak
fda
flagship pioneering
fulcrum therapeutics
ginkgo bioworks
hydrocephalus
hydrocephalus association
hyperammonemia
implantable medical devices
insulated genomic domains
investing
james collins
What
called
3
×
lands
medicines
new
absorb
address
aims
approach
bacteria
based
biology
biotech
bioworks
body
brain
builds
cerevasc
company
comprised
debuts
developer
developing
device
drain
drugs
engineered
epigenetic
epigenetics
faster
field
flagship’s
fluid
ginkgo
hydrocephalus
living
medical
morning
omega
pressure
ramp
Language
unset
Current search:
xconomy.com
×
deals
×
called
×
@xconomy.com
3 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D